The 5 tests your doctor never orders for thyroid

If you are on thyroid medication and you still do not feel well, you are not imagining it. You are also not alone. Roughly one in ten adult Indian women - and a rising share of men - are on thyroxine for hypothyroidism. A substantial share of them will tell you, if asked honestly, that the medication has never quite resolved their symptoms. The fatigue lingers. The hair fall continues. The weight refuses to move. The mind is foggier than it used to be.

When they raise this with their doctor, they usually hear a version of the same three sentences: "Your TSH is in range." "It takes time." "You may need a slight dose adjustment."

What they are rarely told is that the standard thyroid panel - TSH on its own, or TSH plus T4 - does not actually describe the thyroid. It describes one narrow slice of it. The reason symptoms persist is almost always visible on tests that were never ordered.

This article walks through the five tests that, in our experience across several thousand Indian thyroid patients, most consistently explain the gap between "TSH in range" and "I still feel unwell." We will also walk through how these results change the actual treatment plan, and show three real cases where they have.

The problem with TSH alone

TSH is a pituitary hormone, not a thyroid hormone. It is the brain's signal to the thyroid: make more hormone. When the thyroid is underperforming, TSH rises. When medication floods the system, TSH falls. That is a useful but very indirect measure of whether the thyroid is actually doing its work in the tissues.

You can have a "normal" TSH and:

• A thyroid gland under active autoimmune attack
• A failure to convert T4 (the storage form) into T3 (the active form) at the cell level
• High reverse T3 blocking the active hormone at the receptor
• A gut that is not absorbing your medication
• A nutrient deficiency that is preventing hormone conversion

In each of these scenarios, the lab looks "fine." The patient does not feel fine. A good clinician reads the patient; a thorough clinician adds the tests that explain the gap.

Test 1: Anti-TPO and Anti-Thyroglobulin antibodies

This is the single most important test that most hypothyroid patients have never had. Anti-TPO and anti-Tg antibodies measure autoimmune attack on the thyroid itself - Hashimoto's thyroiditis. An estimated 70-80% of hypothyroidism in Indian women is autoimmune in origin, but because the antibodies do not change the decision to prescribe thyroxine, many doctors simply do not order them.

The problem is that not knowing your antibody status changes your entire treatment philosophy.

If your hypothyroidism is autoimmune, the thyroid gland itself is a downstream victim. The upstream drivers are immune dysregulation, gut barrier compromise, micronutrient deficiency, and, often, food triggers. Giving thyroxine without addressing those drivers is like replacing the water in a leaking bucket every morning. The medication dose creeps up because the immune system keeps damaging the thyroid.

If your antibodies are high (anti-TPO above 35 IU/mL, anti-Tg above 40) and your gland is still autoimmune-active, you have a real opportunity: reduce the antibodies and you slow the disease.

What actually reduces antibodies:

• Correcting vitamin D to 50-70 ng/mL
• Selenium at 100-200 mcg/day
• Gluten elimination trial (results vary; in about half of Hashimoto's patients, gluten is a clear trigger)
• Gut barrier repair
• Stress physiology changes
• Addressing any latent infections

In our cohort, anti-TPO typically falls 30-60% over six months with a structured root-cause protocol, and many patients see their dose plateau or reduce for the first time in years.

Test 2: Free T3 and Reverse T3

TSH and free T4 together describe how much hormone you are being given and how the pituitary sees it. Neither describes how much active hormone is reaching the cells. That job belongs to free T3 and reverse T3.

Your body converts T4 (inactive storage hormone, which is what thyroxine medication is) into T3 (the active form that drives metabolism) and, sometimes, into reverse T3 (an inactive mirror image that occupies the receptor without doing any work).

When the body is stressed, inflamed, nutrient-deficient, or in prolonged calorie restriction, the conversion shifts: less T4 becomes T3, more T4 becomes reverse T3. The result is a patient on "enough" thyroxine whose active hormone at the cell level is low, whose reverse T3 is blocking receptors, and whose symptoms are entirely explained - but whose TSH and free T4 look perfect.

What to look for:

• Free T3 in the upper half of the reference range is what symptomatic patients usually need to feel well. A free T3 at the bottom of the range is a common silent cause of fatigue.
• A free T3 / reverse T3 ratio above 20 (when both are in the same units) suggests good conversion; below 10 suggests the reverse T3 problem.

This is cheap, available in India, and almost never on the panel. It is the single test that most often changes a treatment plan in our clinic.

Test 3: Fasting insulin and HOMA-IR

This is the test that endocrinology has been slowest to embrace as a thyroid test, but the biology is clear. Insulin resistance and thyroid dysfunction are deeply entangled. High insulin disrupts the T4-to-T3 conversion enzyme system. Chronic insulin resistance drives inflammation, which in turn increases reverse T3. And the two conditions share common upstream drivers - gut, sleep, stress, nutrient deficiency.

Patients with stubborn weight gain on thyroid medication are almost always being under-treated for the insulin-resistance side of their picture. Treating the thyroid without treating the insulin makes the weight management near impossible - because the weight is not principally a thyroid problem.

The simple panel:

• Fasting insulin (target under 10)
• HOMA-IR (target under 2)
• Triglyceride/HDL ratio (target under 2)

When these normalise, free T3 often improves without any change in thyroid dose. The systems are linked.

Test 4: Inflammation - hs-CRP

A high-sensitivity CRP (hs-CRP) is a generic marker of systemic inflammation. It is not specific to thyroid; it is specific to the environment the thyroid is trying to work in. Inflammation blocks T4-to-T3 conversion, raises reverse T3, and worsens autoimmune activity.

An hs-CRP above 1.0 mg/L is unfavourable. Above 3.0 is high. We routinely see thyroid patients with an hs-CRP of 4-6 who have never been told inflammation might be relevant to their fatigue and brain fog.

Where does the inflammation come from, in a thyroid context?

• Fatty liver (very common in Indian patients)
• Gut dysbiosis and barrier compromise
• Visceral fat
• Untreated periodontal disease
• Chronic poor sleep
• Latent viral load (EBV, HSV - rarely chased clinically)
• Autoimmune activity itself (a vicious feedback loop)

Reducing inflammation is rarely a single intervention. It is a protocol - usually a combination of nutrition, gut repair, vitamin D, omega-3, sleep, and stress work. When it works, free T3 rises and the patient feels like themselves again.

Test 5: Gut and micronutrient panel

The thyroid depends on the gut for three reasons.

First, thyroid hormone conversion happens substantially in the gut via gut-bacteria-mediated enzymes. A disrupted microbiome reduces T3 availability.

Second, thyroxine medication absorption depends on gut conditions - coeliac disease, H. pylori, SIBO, chronic PPI use, and food timing all change how much of the pill is actually entering the body. Patients whose dose keeps rising despite compliance are often malabsorbing, not under-dosed.

Third, the nutrient substrates for thyroid hormone and its conversion - iodine, selenium, iron, zinc, vitamin D, tyrosine, B12 - come through the gut. Deficiency in any of these limits what the thyroid can produce, even when the gland is willing.

The panel we routinely run in thyroid patients:

• Vitamin D (target 50-70 ng/mL, not just "normal")
• B12 (target 500+ pg/mL, not just above the deficiency cut-off)
• Ferritin (target 50+, ideally 70-100 for women with hair fall)
• Selenium (often inferred; serum testing is variable)
• Zinc (RBC zinc if possible)
• Thorough gut history - reflux, bowel patterns, antibiotic use, PPI history
• Consideration of stool testing or H. pylori testing where indicated

Most thyroid patients we see are iron-deficient, vitamin-D-deficient, or both. Both deficiencies directly impair the thyroid and both are ignored when the only question being asked is "what is your TSH."

Case study - Priya, 38, Bengaluru

Priya had been on thyroxine for eleven years. Starting dose 50 mcg. Current dose 125 mcg, with another dose increase being discussed. Her symptoms: fatigue, hair thinning, 8 kg of unshakeable weight over the last five years, cold hands, constipation, fog in meetings.

Her previous doctor's file: a series of TSH values, all in the 2.4-3.8 range, adjusted quarterly. No other thyroid tests. No antibodies. No nutrient panel. No insulin.

Our extended panel:

• TSH 2.9, Free T4 1.3, Free T3 2.4 (low in a 2.0-4.4 range) - the active hormone was low
• Reverse T3 26 (high), ratio 9.2 (poor)
• Anti-TPO 280, Anti-Tg 85 (strongly autoimmune)
• Fasting insulin 17, HOMA-IR 3.8
• hs-CRP 3.6
• Vitamin D 13, Ferritin 12, B12 230
• Ultrasound: thyroid heterogeneous, consistent with Hashimoto's; Grade 1 fatty liver

Priya's thyroid dose had been rising not because of gland failure, but because her T4-to-T3 conversion was failing. Her active hormone at the cell level was low. Her autoimmune activity was pulling the gland down. Her insulin resistance and inflammation were blocking conversion. Her iron was too low to support hair growth or hormone production.

Protocol, six months: gluten removal for an 8-week trial (meaningful improvement at week 5), vitamin D to therapeutic, iron repletion, selenium and zinc, gut repair, omega-3, resistance training, sleep at consistent hours. Thyroid dose was held steady, not adjusted, during the first three months.

Six months:

• Free T3 up to 3.4, Reverse T3 down to 16
• Anti-TPO down to 120, Anti-Tg to 28
• Fasting insulin 8, HOMA-IR 1.5
• hs-CRP 0.9, Vitamin D 58, Ferritin 68
• Weight down 5 kg, hair regrowth visible, constipation resolved, fog gone

Thyroid dose was reduced from 125 mcg to 100 mcg at month seven and to 75 mcg at month twelve under endocrinologist supervision. For the first time in over a decade, Priya's dose is going in the right direction.

Case study - Deepak, 46, Delhi

Deepak is a senior executive, male, which immediately places him outside the usual thyroid-patient mental model. He had been diagnosed four years earlier with mild hypothyroidism - TSH 6.8, negative antibodies on a single test, started on 50 mcg. He was not feeling better. His endocrinologist had told him the thyroid was "a minor factor" and to focus on lifestyle.

The lifestyle advice was not wrong. The thyroid framing was. A male with new-onset hypothyroidism in his forties is a pattern that warrants careful workup, not dismissal.

Extended panel:

• TSH 2.4, Free T4 1.2, Free T3 2.1 (low)
• Reverse T3 28, ratio 7.5 (poor)
• Anti-TPO 45 (newly positive - had been borderline previously)
• Fasting insulin 22, HOMA-IR 5.2
• ALT 68, Ultrasound Grade 2 fatty liver
• hs-CRP 4.8
• Vitamin D 14, B12 260, Ferritin 290 (high - inflammatory pattern)
• Sleep study (initiated because of neck circumference): moderate obstructive sleep apnoea

Deepak's thyroid problem was real, but it was secondary. The primary driver was metabolic: insulin resistance, fatty liver, inflammation, and untreated sleep apnoea. The immune system was progressively pulling the thyroid into the picture (newly positive antibodies). His free T3 was low not because his dose was inadequate but because his conversion was impaired.

Protocol: CPAP, structured lower-carbohydrate food plan, resistance training three times a week, liver support, vitamin D and B12 repletion, selenium, omega-3, gluten trial (mild response), 11 PM sleep lights-out.

Twelve months:

• Free T3 3.4, Reverse T3 14
• Anti-TPO 18 (back into uncertain range)
• Fasting insulin 8, HOMA-IR 1.7
• ALT 28, Ultrasound clear
• hs-CRP 1.0
• Waist down 11 cm, sleep transformed by CPAP

Thyroid dose was reduced from 50 mcg to 25 mcg at month nine, and discontinued at month fourteen under joint medical supervision, with monitoring. TSH has remained at 2.0-2.8 off medication for eight months. Whether he will need medication again long-term is an open question. What is not open is that the full picture changed his trajectory.

Case study - Savita, 41, Jaipur

Savita had the most frustrating thyroid story we hear most often: thyroid dose had gone from 75 to 200 mcg over twelve years, her TSH was always "in range," and her symptoms had never resolved. She had three children, a job, and a deeply tired mother.

Every thyroid panel over a decade had been TSH and T4 only. No antibodies. No free T3. No nutrient workup.

Extended panel:

• TSH 1.8, Free T4 1.5 (high-normal from the high dose), Free T3 2.0 (low)
• Reverse T3 31 (high), ratio 6.5 (very poor)
• Anti-TPO 420 (high), Anti-Tg 180
• Fasting insulin 13, HOMA-IR 2.7
• hs-CRP 2.4
• Vitamin D 8 (severe deficiency), Ferritin 9 (very low), B12 195
• Chronic H. pylori infection (treated during evaluation)
• Positive gluten antibodies on a proper panel, no biopsy-proven coeliac

Savita's picture was a long-standing Hashimoto's with severe malabsorption (H. pylori, and what looked like gluten sensitivity), which explained both the rising dose (poor absorption) and the persistent symptoms (very low ferritin, very low vitamin D, poor conversion).

Protocol: H. pylori eradication (short course antibiotics under physician supervision), full gluten elimination, iron and vitamin D repletion to therapeutic, selenium, thyroxine taken exactly on protocol (60 min before food, no coffee within the window, no calcium or iron within 4 hours), gut barrier repair, and, importantly, dose was not altered in the first three months.

Eighteen months:

• Free T3 3.6, Reverse T3 15
• Anti-TPO 140, Anti-Tg 55
• Ferritin 85, Vitamin D 62, B12 520
• hs-CRP 0.6
• TSH 2.0, dose reduced from 200 mcg to 100 mcg in three measured steps

Savita is a patient the standard system had failed for twelve years. The tests that would have explained her picture were available, inexpensive, and simply not ordered. Her story is, unfortunately, not rare.

What to ask for

If you are on thyroid medication and still not well, ask your treating doctor for:

1. Anti-TPO and Anti-Tg antibodies
2. Free T3 and Reverse T3 (with the ratio)
3. Fasting insulin and HOMA-IR
4. hs-CRP
5. Vitamin D, B12, Ferritin (with targets that are optimal, not just "not deficient"), and a careful gut history

If the response is that these tests are "not necessary," that is a clinical judgement you are entitled to question - or to seek a second opinion on. The evidence that these tests change outcomes in symptomatic hypothyroid patients is substantial and growing.

The principle underneath

A thyroid panel with only TSH is like judging a factory by looking at the letters leaving the mailbox. It tells you the mailroom is functioning. It says almost nothing about the supply chain, the equipment, the workforce, or the final product reaching the customer.

The five tests in this article are how you look inside the factory. They are what turn "your TSH is fine" into "here is actually what is going on." And they are what change your dose curve from an endless upward line into something that can finally go the other way.

If you have been told your thyroid is "controlled" and you do not feel well, you are not wrong. Your doctor is not lying. You are simply looking at too small a window. Open the window.